Art

J-GLOBAL ID：201902266053308156   Reference number：19A2188746

Infectious disease and infection control in the era of the AMR action plan-Epidemiological molecular characterization and clinical presentation of CA-MRSA in Japan-

AMR対策アクションプラン時代の感染症診療・対策-わが国におけるCA-MRSAの疫学情報と臨床像-

Author (1)： YAMAGUCHI TETSUO (東邦大 医 微生物・感染症学)
Material： 日本化学療法学会雑誌  (Japanese Journal of Chemotherapy)
Volume： 67  Issue： 5  Page： 567-576  Publication year： Sep. 10, 2019 
JST Material Number： F0608A  ISSN： 1340-7007  CODEN： NKRZE5  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *MRSA ,...
Semi thesaurus term： mecA ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2188746&from=J-GLOBAL&jstjournalNo=F0608A") }}

JST classification (4)： Clinical application of antibiotics acting on pathogenic organisms  (GX05030N) ,  Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Clinical application of antibacterial drugs  (GW17030D) ,  Physiology and pathogenicity of microbial infection  (EG03053T)

Reference (23)：

• Anonymous: “Celbemom”-resistant staphylococci. Br Med J 1961; 1: 113-4
• Hiramatsu K: Molecular evolution of MRSA. Microbiol Immunol 1995; 39: 531-43
• Enright M C, Robinson D A, Randle G, Feil E J, Grundmann H, Spratt B G: The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002; 99: 7687-92
• Howden B P, Davies J K, Johnson P D, Stinear T P, Grayson M L: Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010; 23: 99-139
• Moran G J, Krishnadasan A, Gorwitz R J, Fosheim G E, McDougal L K, Carey R B, et al: Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74

Terms in the title (6)： 対策 ,  アクションプラン ,  感染症診療 ,  CA-MRSA ,  疫学 ,  臨床像